CAMK1 and acute myeloid leukemia: Similarly, based on our in silico analysis of human samples, the expression of LILRB2 and several CAMKs correlate inversely with the overall survival of AML patients (Fig. 4a–d), and CAMK1 is highly expressed by M5 AML cells (Fig. 4e) as LILRB2 [1].